Literature DB >> 18496506

BMP-7 protects mesangial cells from injury by polymeric IgA.

Wai Long Chan1, Joseph C K Leung, Loretta Y Y Chan, K Y Tam, Sydney C W Tang, Kar Neng Lai.   

Abstract

Bone morphogenetic protein-7 (BMP-7) is a potential therapeutic agent for acute and chronic renal diseases. Here we found that addition of polymeric IgA, isolated from patients with IgA nephropathy, increased the synthesis of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), transforming growth factor-beta (TGF-beta) and fibronectin in cultured human mesangial cells, effects blunted by BMP-7. When mesangial cells were cultured with both polymeric IgA and BMP-7 there was an increase in the expression of peroxisome proliferator-activated receptor-gamma (PPAR-gamma). The activation of NF kappaB and TNF-alpha synthesis induced by polymeric IgA or TNF-alpha were downregulated by BMP-7 or rosiglitazone. BMP-7 inhibited TNF-alpha release from polymeric IgA-stimulated mesangial cells by activation of PPAR-gamma but suppressed TGF-beta release by mechanisms independent of PPAR-gamma. The expression of inhibitory Smad6 and 7 was increased whereas the expression of active Smad2 and 3 was reduced in these mesangial cells by BMP-7. Our study shows that BMP-7 ameliorates IgA nephropathy-derived polymeric IgA-induced TNF-alpha and TGF-beta synthesis in human mesangial cells through multiple mechanisms involving inhibitory Smads and PPAR-gamma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18496506     DOI: 10.1038/ki.2008.209

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  Coding polymorphisms of bone morphogenetic protein 2 contribute to the development of childhood IgA nephropathy.

Authors:  Jin-Soon Suh; Won-Ho Hahn; Jong Seok Lee; Hae Jeong Park; Mi-Ja Kim; Sung Wook Kang; Joo-Ho Chung; Byoung-Soo Cho
Journal:  Exp Ther Med       Date:  2011-01-18       Impact factor: 2.447

2.  Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.

Authors:  Mari Tanaka; Misako Asada; Atsuko Y Higashi; Jin Nakamura; Akiko Oguchi; Mayumi Tomita; Sachiko Yamada; Nariaki Asada; Masayuki Takase; Tomohiko Okuda; Hiroshi Kawachi; Aris N Economides; Elizabeth Robertson; Satoru Takahashi; Takeshi Sakurai; Roel Goldschmeding; Eri Muso; Atsushi Fukatsu; Toru Kita; Motoko Yanagita
Journal:  J Clin Invest       Date:  2010-02-08       Impact factor: 14.808

3.  Update on immunoglobulin A nephropathy, Part I: Pathophysiology.

Authors:  Maurizio Salvadori; Giuseppina Rosso
Journal:  World J Nephrol       Date:  2015-09-06

4.  BMP-7 attenuates adverse cardiac remodeling mediated through M2 macrophages in prediabetic cardiomyopathy.

Authors:  Princess Urbina; Dinender K Singla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-03       Impact factor: 4.733

5.  MicroRNA-23b-3p Deletion Induces an IgA Nephropathy-like Disease Associated with Dysregulated Mucosal IgA Synthesis.

Authors:  Hongzhi Li; Zhichao Chen; Weitian Chen; Jingyi Li; Yunshuang Liu; Hongchuang Ma; Mingming Shi; Xuelian Sun; Xiusong Yao; Zhijun Li; Izabella Z A Pawluczyk; Shuchen Zhang; Jonathan Barratt; Jicheng Lv; Kai Wang; Binghai Zhao
Journal:  J Am Soc Nephrol       Date:  2021-09-03       Impact factor: 14.978

Review 6.  Novel Anti-fibrotic Therapies.

Authors:  Benita L McVicker; Robert G Bennett
Journal:  Front Pharmacol       Date:  2017-05-31       Impact factor: 5.810

7.  Salvianolic acid A alleviates the renal damage in rats with chronic renal failure1.

Authors:  Guangming Zhang; Guanghua Cui; Shuangxi Tong; Qingxian Cao
Journal:  Acta Cir Bras       Date:  2019-02-28       Impact factor: 1.388

Review 8.  Role of bone morphogenetic protein-7 in renal fibrosis.

Authors:  Rui Xi Li; Wai Han Yiu; Sydney C W Tang
Journal:  Front Physiol       Date:  2015-04-23       Impact factor: 4.566

9.  BMP7 reduces the fibrocartilage chondrocyte phenotype.

Authors:  Ellen G J Ripmeester; Marjolein M J Caron; Guus G H van den Akker; Jessica Steijns; Don A M Surtel; Andy Cremers; Laura C W Peeters; Lodewijk W van Rhijn; Tim J M Welting
Journal:  Sci Rep       Date:  2021-10-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.